Financials

  • Market Capitalization 1.55 B
  • Employee 130
  • Founded 2019
  • CEO N/A
  • Website www.septerna.com
  • Headquarter Delaware, United States
  • FIGI BBG014WY1V28
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-25.35
Rapporto prezzo/fatturato
26.85

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2156
GHRS
GH Research PLC - Ordinary Shares
25.35 USD-4.38%-3.17%+19.74%+79.03%1.57 B USD
2159
AVBP
ArriVent BioPharma, Inc. - Common Stock
33.64 USD-0.15%-3.03%+9.51%+53.40%1.57 B USD
2170
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.38 USD-15.14%-16.07%-7.56%+103.02%1.55 B USD
2185
MLTX
MoonLake Immunotherapeutics - Class A Ordinary Shares
20.41 USD+0.25%+9.14%+8.28%+113.49%1.50 B USD